We have recently shown that NOD1 is upregulated in both mouse and human failing myocardium, and its genetic deletion or pharmacological blockade prevents cardiac dysfunction and deleterious remodeling in failing hearts principally by preventing the HF-related Ca2+ mishandling (Val-Blasco et al., 2017a). The gene discussed is NOD1; the disease is hydrops fetalis.